Sort
15,842 grants matching “pancreatic cancer”
Pretargeted Clinical Imaging of CA19.9 in Pancreatic Cancer
$688,387Jason S Lewis · Sloan-Kettering Inst Can Research · U01 · FY2022 · CA
Spectro-Holographic Instrument for Dynamic Sensing of Cancer Progression
$688,217Lev T. Perelman · Beth Israel Deaconess Medical Center · R01 · FY2018 · CA
Using mouse models to probe the relationship of oncogenesis to development and o
$688,149Eric C Holland · Sloan-Kettering Inst Can Research · U01 · FY2010 · CA
Mechanisms of JAG1-mediated immune suppression in the pancreatic cancer microenvironment
$687,824Lan Zhou · Methodist Hospital Research Institute · R01 · FY2024 · CA
Real-time MRI-guided adaptive radiotherapy of unresectable pancreatic cancer
$687,789Ricardo Otazo · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Biomarkers to stratify pain severity and type in pancreatic disease
$687,602Hanno Steen · Boston Children'S Hospital · R01 · FY2024 · DK
Novel Approaches to Targeting Cancers Associated with VHL Mutations
$687,063Ramaprasad Srinivasan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Biomolecular Recognition and Binding Mechanisms
$687,053Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Spectro-Holographic Instrument for Dynamic Sensing of Cancer Progression
$686,599Lev T. Perelman · Beth Israel Deaconess Medical Center · R01 · FY2022 · CA
Novel Therapy to Inhibit IPMN Progression
$686,204Mokenge P. Malafa · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA
NOX family NADPH oxidases: roles in innate immunity and inflammatory disease
$686,028Thomas Leto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Clinical Trials of Flavopiridol with Chemotherapy
$685,940Gary K Schwartz · Sloan-Kettering Inst Can Research · R01 · FY2007 · CA
Mechanisms of Hereditary Pancreatitis
$685,854Baoan Ji · Mayo Clinic Jacksonville · R01 · FY2024 · DK
SOMATIC MOSAICISM FOR CANCER PREDISPOSITION GENES AND PANCREATIC CANCER
$685,600Sloan-Kettering Institute For Cancer Research · · FY2016 · Department of the Army
Overcoming anti-PEG immunity to restore prolonged circulation and efficacy of PEGylated therapeutics
$685,484Samuel Lai · Univ Of North Carolina Chapel Hill · R01 · FY2020 · HL
Engineered anti-PSCA antibodies for immunoPET and targeted therapy of pancreatic cancer
$685,408Anna M Wu · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
Project 2-Identifying and exploiting metabolic vulnerabilities in PDAC
$684,630Nabeel Bardeesy · University Of Tx Md Anderson Can Ctr · P01 · FY2023 · CA
Biophotonics to Couple Pancreatic with Upper GI Screening via Ultrathin Endoscopy
$684,278Vadim Backman · Northwestern University · R01 · FY2015 · CA
Probing cytosolic nucleic acid sensing pathways in cancer
$683,785Ashley Marie Laughney · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
Uncovering Causal Protein Markers to Characterize Pancreatic Cancer Etiology and Improve Risk Prediction
$683,662Lang Wu · Lsu Health Sciences Center · U01 · FY2025 · CA
Mitogenic and Oncogenic Regulation of ERK/RSK Signaling
$683,560John Blenis · Harvard Medical School · R37 · FY2008 · CA
Imaging Acidosis and Immune Therapy in PDAC
$683,503Shari Pilon-Thomas · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2021 · CA
Imaging Acidosis and Immune Therapy in PDAC
$683,503Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2020 · CA
Real-time MRI-guided adaptive radiotherapy of unresectable pancreatic cancer
$683,094Ricardo Otazo · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Total Neoadjuvant Therapy (TNT) for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
$683,063Alice Chia- Chi Wei · Sloan-Kettering Inst Can Research · P50 · FY2023 · CA